Healthcare provider profile · identity verified

Michael Eugene Sands, DO

Family Practice · JEFFERSON CITY, MO · NPI 1558551358

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	556	141
Lisinopril	Lisinopril	503	120
Levothyroxine Sodium	Levothyroxine Sodium	408	102
Omeprazole	Omeprazole	368	86
Gabapentin	Gabapentin	358	74
Amlodipine Besylate	Amlodipine Besylate	267	67
Metformin Hcl	Metformin Hcl	245	59
Pantoprazole Sodium	Pantoprazole Sodium	234	58
Furosemide	Furosemide	233	54
Sertraline Hcl	Sertraline Hcl	230	47
Hydrochlorothiazide	Hydrochlorothiazide	215	50
Tamsulosin Hcl	Tamsulosin Hcl	203	59
Potassium Chloride	Potassium Chloride	188	37
Metformin Hcl Er	Metformin Hcl	182	40
Losartan Potassium	Losartan Potassium	175	48
Montelukast Sodium	Montelukast Sodium	169	39
Rosuvastatin Calcium	Rosuvastatin Calcium	151	33
Ozempic	Semaglutide	150	28
Metoprolol Tartrate	Metoprolol Tartrate	140	35
Metoprolol Succinate	Metoprolol Succinate	133	35
Meloxicam	Meloxicam	132	33
Glimepiride	Glimepiride	130	28
Allopurinol	Allopurinol	124	31
Duloxetine Hcl	Duloxetine Hcl	122	21
Alprazolam	Alprazolam	117	25
Fluoxetine Hcl	Fluoxetine Hcl	117	21
Pravastatin Sodium	Pravastatin Sodium	116	33
Trazodone Hcl	Trazodone Hcl	110	22
Citalopram Hbr	Citalopram Hydrobromide	105	20
Simvastatin	Simvastatin	103	26
Tramadol Hcl	Tramadol Hcl	99	35
Azithromycin	Azithromycin	93	73
Finasteride	Finasteride	87	17
Ezetimibe	Ezetimibe	83	19
Fluticasone Propionate	Fluticasone Propionate	78	23
Zolpidem Tartrate	Zolpidem Tartrate	78	17
Pregabalin	Pregabalin	77	14
Albuterol Sulfate Hfa	Albuterol Sulfate	74	36
Clonazepam	Clonazepam	74	14
Atenolol	Atenolol	73	18
Eliquis	Apixaban	73	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	71	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	69	17
Clopidogrel	Clopidogrel Bisulfate	66	19
Donepezil Hcl	Donepezil Hcl	62	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	61	19
Glipizide	Glipizide	58	14
Escitalopram Oxalate	Escitalopram Oxalate	57	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	57	14
Baclofen	Baclofen	54	11
Carvedilol	Carvedilol	53	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	53	15
Oxybutynin Chloride	Oxybutynin Chloride	51	11
Celecoxib	Celecoxib	49	14
Hydroxyzine Hcl	Hydroxyzine Hcl	48	15
Lorazepam	Lorazepam	46	12
Lovastatin	Lovastatin	45	12
Warfarin Sodium	Warfarin Sodium	44	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	43	suppressed
Spironolactone	Spironolactone	42	11
Venlafaxine Hcl Er	Venlafaxine Hcl	42	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	41	11
Bupropion Xl	Bupropion Hcl	36	suppressed
Buspirone Hcl	Buspirone Hcl	36	suppressed
Glipizide Er	Glipizide	36	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	35	suppressed
Famotidine	Famotidine	35	suppressed
Xarelto	Rivaroxaban	35	suppressed
Methylprednisolone	Methylprednisolone	34	32
Testosterone Cypionate	Testosterone Cypionate	34	15
Propranolol Hcl	Propranolol Hcl	33	suppressed
Alendronate Sodium	Alendronate Sodium	32	suppressed
Ropinirole Hcl	Ropinirole Hcl	32	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	32	suppressed
Synthroid	Levothyroxine Sodium	32	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	31	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	29	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	28	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	28	22
Pioglitazone Hcl	Pioglitazone Hcl	27	suppressed
Tizanidine Hcl	Tizanidine Hcl	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	17
Myrbetriq	Mirabegron	26	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	26	suppressed
Diazepam	Diazepam	23	suppressed
Diltiazem Hcl	Diltiazem Hcl	23	suppressed
Levetiracetam	Levetiracetam	23	suppressed
Lidocaine	Lidocaine	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Nystatin	Nystatin	22	12
Sotalol	Sotalol Hcl	22	suppressed
Benazepril Hcl	Benazepril Hcl	20	suppressed
Januvia	Sitagliptin Phosphate	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	12
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	19	suppressed
Lansoprazole	Lansoprazole	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Ondansetron Odt	Ondansetron	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Amoxicillin	Amoxicillin	18	14
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Tradjenta	Linagliptin	18	suppressed
Fluconazole	Fluconazole	17	15
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	17	16
Irbesartan	Irbesartan	17	suppressed
Topiramate	Topiramate	17	suppressed
Constulose	Lactulose	16	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Xultophy 100-3.6	Insulin Degludec/Liraglutide	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	15	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Klor-Con M20	Potassium Chloride	14	suppressed
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Temazepam	Temazepam	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Matzim La	Diltiazem Hcl	13	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	13	suppressed
Balsalazide Disodium	Balsalazide Disodium	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Cephalexin	Cephalexin	12	12
Janumet	Sitagliptin Phos/Metformin Hcl	12	suppressed
Jardiance	Empagliflozin	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Entacapone	Entacapone	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Humalog	Insulin Lispro	11	suppressed
Nyamyc	Nystatin	11	suppressed
Prenatal Vitamin Plus Low Iron	Pnv,calcium 72/Iron/Folic Acid	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Theophylline Er	Theophylline Anhydrous	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed
Tymlos	Abaloparatide	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed
Westab Plus	Pnv,calcium 72/Iron/Folic Acid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error